0001593968-24-000195.txt : 20240131 0001593968-24-000195.hdr.sgml : 20240131 20240131174741 ACCESSION NUMBER: 0001593968-24-000195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240125 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parker Geoffrey M. CENTRAL INDEX KEY: 0001491874 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 24584174 MAIL ADDRESS: STREET 1: 15 RIORDAN PLACE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 primary_01.xml PRIMARY DOCUMENT X0508 4 2024-01-25 0001737287 Allogene Therapeutics, Inc. ALLO 0001491874 Parker Geoffrey M. 210 EAST GRAND AVE SOUTH SAN FRANCISCO 94080 true CHIEF FINANCIAL OFFICER false Common Stock 2024-01-25 4 A false 29400 0 A 819400 D Stock Option (Right to buy) 3.2 2024-01-25 4 A false 103939 0 A 2034-01-25 Common Stock 103939 103939 D 1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter. /s/Earl Douglas, Attorney-in-Fact 2024-01-31